We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

103 hedge funds and large institutions have $185M invested in Antares Pharma, Inc. in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $640K | Put options by funds: $176K

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

61% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 18

30% more capital invested

Capital invested by funds: $142M → $185M (+$43.3M)

21% more funds holding

Funds holding: 85 → 103 (+18)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
103
Holders Change
+18
Holders Change %
+21.18%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
36
Increased
29
Reduced
18
Closed
17
Calls
$640K
Puts
$176K
Net Calls
+$464K
Net Calls Change
+$222K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.8M
2
State Street
State Street
Massachusetts
+$5.54M
3
Northern Trust
Northern Trust
Illinois
+$3.88M
4
PA
Perceptive Advisors
New York
+$3.83M
5
Deutsche Bank
Deutsche Bank
Germany
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$8.5M
2
BC
Broadfin Capital
New York
-$8.05M
3
Millennium Management
Millennium Management
New York
-$5.07M
4
KCM
Kingdon Capital Management
New York
-$2.41M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
51
American International Group
New York
$287K +$253K +89,132 New
NFA
52
Nationwide Fund Advisors
Ohio
$260K +$229K +80,791 New
HCM
53
Highbridge Capital Management
New York
$256K +$225K +79,477 New
VOYA Investment Management
54
VOYA Investment Management
Georgia
$210K +$184K +65,073 New
SIC
55
SFE Investment Counsel
California
$193K – – –
NPC
56
National Planning Corporation
California
$186K +$17K +6,000 +11%
Arrowstreet Capital
57
Arrowstreet Capital
Massachusetts
$174K +$153K +54,000 New
OC
58
Oppenheimer & Co
New York
$166K -$15K -5,300 -9%
Commonwealth Equity Services
59
Commonwealth Equity Services
Massachusetts
$159K +$14.1K +4,987 +11%
Simplex Trading
60
Simplex Trading
Illinois
$159K +$141K +49,631 New
Invesco
61
Invesco
Georgia
$153K +$135K +47,561 New
LPL Financial
62
LPL Financial
California
$149K -$7.09K -2,500 -5%
MML Investors Services
63
MML Investors Services
Massachusetts
$139K +$85K +30,000 +228%
Legal & General Group
64
Legal & General Group
United Kingdom
$120K +$106K +37,430 New
AllianceBernstein
65
AllianceBernstein
Tennessee
$119K +$105K +36,900 New
CD
66
Carl Domino
Florida
$105K – – –
CS
67
Credit Suisse
Switzerland
$99K -$59.8K -21,088 -41%
Barclays
68
Barclays
United Kingdom
$98K +$5.75K +2,030 +7%
State Board of Administration of Florida Retirement System
69
State Board of Administration of Florida Retirement System
Florida
$98K +$86.4K +30,473 New
Jacobs Levy Equity Management
70
Jacobs Levy Equity Management
New Jersey
$93K -$310K -109,542 -79%
Creative Planning
71
Creative Planning
Kansas
$85K – – –
Principal Financial Group
72
Principal Financial Group
Iowa
$85K +$74.5K +26,298 New
Wolverine Trading
73
Wolverine Trading
Illinois
$78K -$3.44K -1,214 -5%
Two Sigma Advisers
74
Two Sigma Advisers
New York
$65K +$57K +20,100 New
First Eagle Investment Management
75
First Eagle Investment Management
New York
$64K – – –
1 2
3
4 5

ATRS Hedge Fund Activity: Q2 2017 in Review

103 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2017, worth a combined $185M — up 30% from $142M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ATRS positions and 17 closed out — a net gain of 19 holders — while 29 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was Armistice Capital, cutting an estimated $8.5M.

  • 103 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2017, up from 85 in Q1 2017.
  • Funds reported $185M of Antares Pharma, Inc. stock for Q2 2017, up 30% quarter-over-quarter.
  • 36 funds opened new Antares Pharma, Inc. positions in Q2 2017 and 17 closed out, a net change of +19 holders.
  • The largest Antares Pharma, Inc. buyer in Q2 2017 was BlackRock, an estimated $17.8M added.
  • The largest Antares Pharma, Inc. seller in Q2 2017 was Armistice Capital, an estimated $8.5M sold.

Based on aggregated 13F filings for Q2 2017.